Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deepa Bhojwani

Showing results (51-60 of 125) with videos related to

Pageof 13
Sort By:
Pediatric Blood & Cancer|May 26, 2018
Myeloid lineage switch following chimeric antigen receptor T-cell therapy in a patient with TCF3-ZNF384 fusion-positive B-lymphoblastic leukemiaMatthew J Oberley, Paul S Gaynon, Deepa Bhojwani, et al.
Cancer|March 5, 2013
Prognostic impact of absolute lymphocyte counts at the end of remission induction in childhood acute lymphoblastic leukemiaJeffrey E Rubnitz, Patrick Campbell, Yinmei Zhou, et al.
Journal of Pediatric Hematology/Oncology|November 27, 2013
A phase I study of EZN-3042, a novel survivin messenger ribonucleic acid (mRNA) antagonist, administered in combination with chemotherapy in children with relapsed acute lymphoblastic leukemia (ALL): a report from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortiumElizabeth A Raetz, Debra Morrison, Eleny Romanos-Sirakis, et al.
Blood|October 7, 2017
Phase 1 study of the anti-CD22 immunotoxin moxetumomab pasudotox for childhood acute lymphoblastic leukemiaAlan S Wayne, Nirali N Shah, Deepa Bhojwani, et al.
Leukemia & Lymphoma|August 8, 2024
Pediatric therapy-related hematologic neoplasms show enrichment for <i>KMT2A</i> rearrangement and lymphoblastic phenotypeAlexandra E Kovach, Daria Komova, Albert Itov, et al.
Cancer|February 18, 2021
Phase 1 study of bendamustine in combination with clofarabine, etoposide, and dexamethasone in pediatric patients with relapsed or refractory hematologic malignanciesSima Jeha, Kristine R Crews, Deqing Pei, et al.
Cancer Genetics|December 16, 2021
Acute myeloid leukemia with t(X;6)9p11;q23);MYB-GATA1 and female sex: GATA1 insufficiency may be insufficient for pathogenesisAlexandra E Kovach, Elena Zerkalenkova, Ludmila Zemtsova, et al.
Annals of Hematology|February 23, 2011
Spinal epidural lipomatosis in children with hematologic malignanciesRachel C Brennan, Kathleen J Helton, Deqing Pei, et al.
Blood|September 17, 2011
Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategiesLaura E Hogan, Julia A Meyer, Jun Yang, et al.
Leukemia|February 3, 2021
Increased Incidence of IKZF1 deletions and IGH-CRLF2 translocations in B-ALL of Hispanic/Latino children-a novel health disparityGordana Raca, Hisham Abdel-Azim, Feng Yue, et al.
Pageof 13

Showing results (51-60 of 125) with videos related to

Sort By:
Pageof 13
Pediatric Blood & Cancer|May 26, 2018
Myeloid lineage switch following chimeric antigen receptor T-cell therapy in a patient with TCF3-ZNF384 fusion-positive B-lymphoblastic leukemiaMatthew J Oberley, Paul S Gaynon, Deepa Bhojwani, et al.
Cancer|March 5, 2013
Prognostic impact of absolute lymphocyte counts at the end of remission induction in childhood acute lymphoblastic leukemiaJeffrey E Rubnitz, Patrick Campbell, Yinmei Zhou, et al.
Journal of Pediatric Hematology/Oncology|November 27, 2013
A phase I study of EZN-3042, a novel survivin messenger ribonucleic acid (mRNA) antagonist, administered in combination with chemotherapy in children with relapsed acute lymphoblastic leukemia (ALL): a report from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortiumElizabeth A Raetz, Debra Morrison, Eleny Romanos-Sirakis, et al.
Blood|October 7, 2017
Phase 1 study of the anti-CD22 immunotoxin moxetumomab pasudotox for childhood acute lymphoblastic leukemiaAlan S Wayne, Nirali N Shah, Deepa Bhojwani, et al.
Leukemia & Lymphoma|August 8, 2024
Pediatric therapy-related hematologic neoplasms show enrichment for <i>KMT2A</i> rearrangement and lymphoblastic phenotypeAlexandra E Kovach, Daria Komova, Albert Itov, et al.
Cancer|February 18, 2021
Phase 1 study of bendamustine in combination with clofarabine, etoposide, and dexamethasone in pediatric patients with relapsed or refractory hematologic malignanciesSima Jeha, Kristine R Crews, Deqing Pei, et al.
Cancer Genetics|December 16, 2021
Acute myeloid leukemia with t(X;6)9p11;q23);MYB-GATA1 and female sex: GATA1 insufficiency may be insufficient for pathogenesisAlexandra E Kovach, Elena Zerkalenkova, Ludmila Zemtsova, et al.
Annals of Hematology|February 23, 2011
Spinal epidural lipomatosis in children with hematologic malignanciesRachel C Brennan, Kathleen J Helton, Deqing Pei, et al.
Blood|September 17, 2011
Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategiesLaura E Hogan, Julia A Meyer, Jun Yang, et al.
Leukemia|February 3, 2021
Increased Incidence of IKZF1 deletions and IGH-CRLF2 translocations in B-ALL of Hispanic/Latino children-a novel health disparityGordana Raca, Hisham Abdel-Azim, Feng Yue, et al.
Pageof 13